Diagnosis & ScreeningResearch
Eye-Tracking Technology May Help Identify Early Signs of Autism in Infants
Emerging research explores how eye-tracking could contribute to earlier identification of autism-related traits in infants, opening possibilities for supportive interventions.
Eye-Tracking as an Early Indicator
Research is exploring how eye-tracking technology might contribute to understanding early neurodevelopmental differences. A study in Nature found that infants later identified as autistic showed different patterns of attention to eyes as early as 2-6 months. This builds on earlier work like a 2022 Nature study that examined eye-tracking as a potential biomarker.
Practical Applications
The feasibility of brief eye-tracking protocols is being investigated. The 2024 Nature study explored a 2-minute protocol that could potentially be adapted for clinical settings. Research like this Springer study is examining how such tools might complement existing screening methods.
Potential Benefits
Earlier identification of neurodevelopmental differences could allow for timely support. As noted in The Transmitter, understanding early signs may help families access resources. However, autistic advocates emphasize the importance of approaches that respect neurodiversity, as discussed in this Frontiers review.
Considerations and Future Directions
While promising, researchers caution that eye-tracking isn't yet ready as a standalone tool. Questions remain about its applicability across diverse populations and settings. As highlighted in NIH research, any screening approach must balance potential benefits with ethical considerations about early identification.
Sources
- 01Early Warning Signs of Autism: A Systematic Review of Nonverbal Behavioral Markers and Early Developmental Red Flags in Children Under 36 Months
- 02Feasibility of a 2-minute eye-tracking protocol to support the early identification of autism
- 03Classic sign of autism appears in early infancy, study says
- 04Eye Tracking Screening for ASD in Nursery: Is Early Diagnosis ...
Common questions
Behind the brief
Adversarial editorial review
Open thread